The development of medicine concerns all mankind, but the pharmaceutical industry is often affected by a variety of factors, Changzhou Wisdom Drugs is committed to the pharmaceutical API industry for many years, pharmaceutical intermediates, API is our main field. Through the industry platform, we have learned that various large pharmaceutical companies in the global pharmaceutical market are often affected by the following:
- Fake products
Counterfeit drugs are drugs that are made in the pharmaceutical process using low-quality raw materials, incorrect ingredients, or the wrong dosage. The negative impact on pharmaceutical companies’ supply chains when they are affected by counterfeit drugs and products can even be global.
Manufacturers of counterfeit products may intentionally sell counterfeit products in the form of mislabeling and intellectual property rights infringement, which may eventually lead to drug side effects and complications. And have a negative impact on end manufacturers.
This has led to the development of medical monitoring services and counterfeit drug identification techniques, such as the use of mass spectrometry, infrared spectroscopy (FTIR), nuclear magnetic resonance spectroscopy, Raman spectroscopy and gas chromatography-mass spectrometry (GC-MS) to detect fake samples.
- Increased trade taxes
Pharmaceutical companies generally produce products at the retail end in primary markets such as the United States and Europe. Apis for end products are often sourced from developing countries such as Brazil, China, India and Israel. So tariffs and trade taxes are part of the cost of drug manufacturing.
Since in previous years, the Trump administration imposed double-digit tariffs on companies active in outsourcing drug manufacturing to promote “Made in America,” these regulations have subsequently led pharmaceutical raw material manufacturers to use cheaper raw materials in response to higher trade taxes.
- Regulatory delays
Pharmaceutical raw material suppliers in the United States need FDA and EMA approval to sell their products, and the government and medical associations strictly regulate drug safety because public safety and health issues are of Paramount importance.
Delays in the approval process can delay the time to market, which can lead to a number of related issues such as patent validity. Production delays can seriously affect drug manufacturers’ profit margins, thereby hampering the drug’s market share.
About Wisdom Drugs
Wisdom Drugs Co .,Ltd was founded in Sep. 2011 whose headquarter located in Changzhou Creative Industry Park, having a branch in India. The company’s R&D center is engaged in not only the process development of APIs, intermediates, poly-peptide compounds and heterocyclic compounds,but also the optimization and production. We are devoted to the synthesis customization and the technology transfer, enabling compounds to be scaled from laboratory to commercial to meet the requirements of different customers.
